Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Whole anterior segment proton beam radiotherapy for diffuse iris melanoma.

Konstantinidis L, Roberts D, Errington RD, Kacperek A, Damato B.

Br J Ophthalmol. 2013 Apr;97(4):471-4. doi: 10.1136/bjophthalmol-2012-302659. Epub 2013 Jan 7.

PMID:
23298884
2.

Recurrence of iris melanoma after proton beam therapy.

Sandinha MT, Kacperek A, Errington RD, Coupland SE, Damato B.

Br J Ophthalmol. 2014 Apr;98(4):484-7. doi: 10.1136/bjophthalmol-2013-303321. Epub 2014 Jan 10.

PMID:
24414401
3.

Proton beam radiotherapy of diffuse iris melanoma in 54 patients.

Willerding GD, Cordini D, Hackl C, Karle B, Lakotka N, Foerster MH, Bechrakis NN, Heufelder J, Moser L, Joussen AM.

Br J Ophthalmol. 2015 Jun;99(6):812-6. doi: 10.1136/bjophthalmol-2014-305174. Epub 2014 Dec 10.

PMID:
25505288
4.

Proton beam radiotherapy of iris melanoma.

Damato B, Kacperek A, Chopra M, Sheen MA, Campbell IR, Errington RD.

Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):109-15.

PMID:
16111578
5.

Ruthenium plaque radiation therapy for iris and iridociliary melanomas.

Razzaq L, Keunen JE, Schalij-Delfos NE, Creutzberg CL, Ketelaars M, de Keizer RJ.

Acta Ophthalmol. 2012 May;90(3):291-6. doi: 10.1111/j.1755-3768.2010.01967.x. Epub 2010 Jul 29.

6.

Ciliary body melanoma with limited nodular extrascleral extension and diffuse iris-angle infiltration treated by whole anterior segment plaque radiotherapy.

Gray ME, CorrĂȘa ZM, Augsburger JJ, Barrett W.

Int Ophthalmol. 2007 Aug;27(4):273-6. Epub 2007 Apr 28.

PMID:
17468833
7.

Proton beam therapy for presumed and confirmed iris melanomas: a review of 36 cases.

Rahmi A, Mammar H, Thariat J, Angellier G, Herault J, Chauvel P, Kodjikian L, Denis P, Grange JD.

Graefes Arch Clin Exp Ophthalmol. 2014 Sep;252(9):1515-21. doi: 10.1007/s00417-014-2735-y. Epub 2014 Jul 20.

PMID:
25038910
8.

Baerveldt shunts in the treatment of glaucoma secondary to anterior uveal melanoma and proton beam radiotherapy.

Sharkawi E, Oleszczuk JD, Bergin C, Zografos L.

Br J Ophthalmol. 2012 Aug;96(8):1104-7. doi: 10.1136/bjophthalmol-2011-301420. Epub 2012 May 24.

PMID:
22628537
9.

Proton beam therapy for iris melanoma: a review of 15 cases.

Rundle P, Singh AD, Rennie I.

Eye (Lond). 2007 Jan;21(1):79-82. Epub 2006 Jan 13.

PMID:
16410818
10.

Plaque radiotherapy for residual or recurrent iris melanoma after surgical resection in 32 cases.

Shah SU, Shields CL, Bianciotto C, Emrich J, Komarnicky L, Shields JA.

Ophthalmology. 2012 Apr;119(4):838-842.e2. doi: 10.1016/j.ophtha.2011.09.039. Epub 2011 Nov 30.

PMID:
22133794
11.

Custom-designed plaque radiotherapy for nonresectable iris melanoma in 38 patients: tumor control and ocular complications.

Shields CL, Naseripour M, Shields JA, Freire J, Cater J.

Am J Ophthalmol. 2003 May;135(5):648-56.

PMID:
12719072
12.

Proton beam therapy for iris melanomas.

Lumbroso-Le Rouic L, Delacroix S, Dendale R, Levy-Gabriel C, Feuvret L, Noel G, Plancher C, Nauraye C, Garcia P, Calugaru V, Asselain B, Desjardins L.

Eye (Lond). 2006 Nov;20(11):1300-5. Epub 2006 Nov 18.

PMID:
16294207
13.

Treatment of non-resectable malignant iris tumours with custom designed plaque radiotherapy.

Shields CL, Shields JA, De Potter P, Singh AD, Hernandez C, Brady LW.

Br J Ophthalmol. 1995 Apr;79(4):306-12.

14.

Iris melanoma management with iodine-125 plaque radiotherapy in 144 patients: impact of melanoma-related glaucoma on outcomes.

Shields CL, Shah SU, Bianciotto CG, Emrich J, Komarnicky L, Shields JA.

Ophthalmology. 2013 Jan;120(1):55-61. doi: 10.1016/j.ophtha.2012.06.053. Epub 2012 Sep 12.

PMID:
22980742
15.

Proton radiotherapy as an alternative to exenteration in the management of extended conjunctival melanoma.

Wuestemeyer H, Sauerwein W, Meller D, Chauvel P, Schueler A, Steuhl KP, Bornfeld N, Anastassiou G.

Graefes Arch Clin Exp Ophthalmol. 2006 Apr;244(4):438-46. Epub 2005 Aug 23.

PMID:
16133022
16.

Primary iris melanoma: diagnostic features and outcome of conservative surgical treatment.

Conway RM, Chua WC, Qureshi C, Billson FA.

Br J Ophthalmol. 2001 Jul;85(7):848-54.

17.

Factors associated with elevated intraocular pressure in eyes with iris melanoma.

Shields CL, Materin MA, Shields JA, Gershenbaum E, Singh AD, Smith A.

Br J Ophthalmol. 2001 Jun;85(6):666-9.

18.

Lack of radiation maculopathy after palladium-103 plaque radiotherapy for iris melanoma.

Yousef YA, Finger PT.

Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):1107-12. doi: 10.1016/j.ijrobp.2011.09.033. Epub 2011 Dec 13.

PMID:
22172910
19.

Anterior segment tumor biopsy using an aspiration cutter technique: clinical experience.

Petousis V, Finger PT, Milman T.

Am J Ophthalmol. 2011 Nov;152(5):771-5.e1. doi: 10.1016/j.ajo.2011.04.032. Epub 2011 Jul 27.

PMID:
21794840
20.

Uveal tumour resection.

Char DH, Miller T, Crawford JB.

Br J Ophthalmol. 2001 Oct;85(10):1213-9.

Supplemental Content

Support Center